Related Experiment Video
Updated: Jul 15, 2025

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
Effects of Strategy-Based Memory Training for Older Adults: Do Booster Sessions Prompt Long-Term Benefits?
Erika Borella1, Enrico Sella1, Anna Simonetto1
1Department of General Psychology, University of Padova, 35131 Padova, Italy.
Abstract:
This study examined the efficacy of a strategy-based memory training for older adults at short- and long-term with two (5- and 11 months) follow-ups. We also explored whether booster sessions (additional training before the first follow-up) facilitated the maintenance of benefits. Thirty-three older adults received a training based on the teaching of different effective memory strategies. One group completed three booster sessions before the 5 months follow-up. Training gains were examined using a word-list and a face-surname association recall tasks, and transfer effects with a grocery-word list (GL) recall task, a working memory (WM) measure, and a perceived memory functioning questionnaire. Training gains and transfer effects to the WM measure emerged and were maintained up to the second follow-up. No benefits for the GL and perceived memory functioning were found. The "boosted" group had only a slight advantage-in one of the transfer tasks-as shown by effect sizes. This pilot study confirms the efficacy of strategy-based memory training in supporting older adults' memory performance up to 11 months since training completion. However, booster sessions seem not to make a clear difference in prompting long-lasting benefits. Training features capable of fostering generalized, prolonged effects are worth investigating.
Related Concept Videos
Chunking and Rehearsal in Sensory Memory
Cognitive Development During Adulthood
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Elaborative Rehearsals
The effectiveness of...
Working Memory
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

